Matches in SemOpenAlex for { <https://semopenalex.org/work/W2474833575> ?p ?o ?g. }
- W2474833575 endingPage "784" @default.
- W2474833575 startingPage "774" @default.
- W2474833575 abstract "ABSTRACT Clostridium difficile infection (CDI), a leading cause of nosocomial infection, is a serious disease in North America, Europe, and Asia. CDI varies greatly from asymptomatic carriage to life-threatening diarrhea, toxic megacolon, and toxemia. The incidence of community-acquired infection has increased due to the emergence of hypervirulent antibiotic-resistant strains. These new strains contribute to the frequent occurrence of disease relapse, complicating treatment, increasing hospital stays, and increasing morbidity and mortality among patients. Therefore, it is critical to develop new therapeutic approaches that bypass the development of antimicrobial resistance and avoid disruption of gut microflora. Here, we describe the construction of a single heteromultimeric VHH-based neutralizing agent (VNA) that targets the two primary virulence factors of Clostridium difficile , toxins A (TcdA) and B (TcdB). Designated VNA2-Tcd, this agent has subnanomolar toxin neutralization potencies for both C. difficile toxins in cell assays. When given systemically by parenteral administration, VNA2-Tcd protected against CDI in gnotobiotic piglets and mice and to a lesser extent in hamsters. Protection from CDI was also observed in gnotobiotic piglets treated by gene therapy with an adenovirus that promoted the expression of VNA2-Tcd." @default.
- W2474833575 created "2016-07-22" @default.
- W2474833575 creator A5010025683 @default.
- W2474833575 creator A5022987623 @default.
- W2474833575 creator A5029101487 @default.
- W2474833575 creator A5031958284 @default.
- W2474833575 creator A5036159485 @default.
- W2474833575 creator A5040138737 @default.
- W2474833575 creator A5045365452 @default.
- W2474833575 creator A5054040744 @default.
- W2474833575 creator A5061102263 @default.
- W2474833575 creator A5065334845 @default.
- W2474833575 creator A5077133720 @default.
- W2474833575 creator A5079171647 @default.
- W2474833575 creator A5091459002 @default.
- W2474833575 date "2016-09-01" @default.
- W2474833575 modified "2023-10-17" @default.
- W2474833575 title "A Tetraspecific VHH-Based Neutralizing Antibody Modifies Disease Outcome in Three Animal Models of Clostridium difficile Infection" @default.
- W2474833575 cites W1545620865 @default.
- W2474833575 cites W1935193502 @default.
- W2474833575 cites W1968019372 @default.
- W2474833575 cites W1968953113 @default.
- W2474833575 cites W1973650764 @default.
- W2474833575 cites W1976784576 @default.
- W2474833575 cites W1978320743 @default.
- W2474833575 cites W1978487895 @default.
- W2474833575 cites W1981520856 @default.
- W2474833575 cites W1984844099 @default.
- W2474833575 cites W1985152764 @default.
- W2474833575 cites W1991984095 @default.
- W2474833575 cites W1994795396 @default.
- W2474833575 cites W2001138774 @default.
- W2474833575 cites W2002134849 @default.
- W2474833575 cites W2004736524 @default.
- W2474833575 cites W2004746023 @default.
- W2474833575 cites W2006558987 @default.
- W2474833575 cites W2013818359 @default.
- W2474833575 cites W2020368956 @default.
- W2474833575 cites W2022202320 @default.
- W2474833575 cites W2025024815 @default.
- W2474833575 cites W2026991426 @default.
- W2474833575 cites W2028813892 @default.
- W2474833575 cites W2034516179 @default.
- W2474833575 cites W2037021601 @default.
- W2474833575 cites W2041054643 @default.
- W2474833575 cites W2043965252 @default.
- W2474833575 cites W2044710722 @default.
- W2474833575 cites W2049511418 @default.
- W2474833575 cites W2050901716 @default.
- W2474833575 cites W2052375392 @default.
- W2474833575 cites W2054395318 @default.
- W2474833575 cites W2059443009 @default.
- W2474833575 cites W2060382765 @default.
- W2474833575 cites W2073971367 @default.
- W2474833575 cites W2075024118 @default.
- W2474833575 cites W2076511957 @default.
- W2474833575 cites W2083323027 @default.
- W2474833575 cites W2096454911 @default.
- W2474833575 cites W2100217852 @default.
- W2474833575 cites W2101182826 @default.
- W2474833575 cites W2102459023 @default.
- W2474833575 cites W2104928240 @default.
- W2474833575 cites W2105413055 @default.
- W2474833575 cites W2106538777 @default.
- W2474833575 cites W2108975442 @default.
- W2474833575 cites W2115583334 @default.
- W2474833575 cites W2118695222 @default.
- W2474833575 cites W2121149847 @default.
- W2474833575 cites W2123146097 @default.
- W2474833575 cites W2123366827 @default.
- W2474833575 cites W2124239976 @default.
- W2474833575 cites W2125658828 @default.
- W2474833575 cites W2129946284 @default.
- W2474833575 cites W2134223885 @default.
- W2474833575 cites W2135136217 @default.
- W2474833575 cites W2137961913 @default.
- W2474833575 cites W2144370711 @default.
- W2474833575 cites W2144646532 @default.
- W2474833575 cites W2146081597 @default.
- W2474833575 cites W2147511770 @default.
- W2474833575 cites W2147741767 @default.
- W2474833575 cites W2151646027 @default.
- W2474833575 cites W2160295333 @default.
- W2474833575 cites W2163758302 @default.
- W2474833575 cites W2165281718 @default.
- W2474833575 cites W2167811982 @default.
- W2474833575 cites W2175097395 @default.
- W2474833575 cites W2178824608 @default.
- W2474833575 cites W2222582869 @default.
- W2474833575 cites W2273363457 @default.
- W2474833575 cites W2322389503 @default.
- W2474833575 cites W2333302180 @default.
- W2474833575 cites W36149503 @default.
- W2474833575 cites W1986266389 @default.
- W2474833575 doi "https://doi.org/10.1128/cvi.00730-15" @default.
- W2474833575 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5014919" @default.
- W2474833575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27413067" @default.
- W2474833575 hasPublicationYear "2016" @default.